Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print


Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com


Buscar en contenido


viernes, 13 de mayo de 2016

Invasive treatment of NSTEMI/UAP

EMCRIT - May 11, 2016 - By Thomas D
"Besides being one of the better study names around, this Norwegian RCT in the Lancet also shifted my prejudice. I was really thinking invasive vs conservative treatment for those over 80 with NSTEMI/UAP would show little difference. Maybe even a win for conservative treatment. But the scales tipped quite heavily in favour of invasive treatment...
Invasive treatment of NSTEMI/UAP is effective, even in the very elderly >80 years old. Mainly by reducing the risk of a recurrent MI by 50% compared with the best medical treatment alone, and also reduces the need for urgent revascularisation. The effect is less clear when patients reach 90. Still, for me, this study shifts my attitude towards invasive treatment of the very elderly."